Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

PrEP news

Show

From To
Who Should Get Pills To Prevent HIV?

During a teleconference Wednesday hosted by the Centers for Disease Control and Prevention, researchers said no more randomized controlled studies are needed to show these methods work. But there will need to be studies to sort out the most effective way to deploy the approaches in different countries and different populations with different HIV rates.

Published
14 July 2011
From
NPR
UNAIDS and WHO hail new results showing that a once-daily pill for HIV-negative people can prevent them from acquiring HIV

“This is a major scientific breakthrough which re-confirms the essential role that antiretroviral medicine has to play in the AIDS response,” said Michel Sidibé, Executive Director of the Joint United Nations Programme on HIV/AIDS (UNAIDS). “These studies could help us to reach the tipping point in the HIV epidemic.”

Published
13 July 2011
From
UNAIDS
AVAC calls for quick action to move landmark HIV prevention results toward lifesaving programs

AVAC has called for ARV-based prevention to be included in national plans, applications to the Global Fund to Fight AIDS, Tuberculosis and Malaria and donor priorities. "We need ambitious pilot and demonstration projects to guide programmatic design, along with national and international guidance on how best to use ARVs as lifesaving prevention tools," said Mitchell Warren.

Published
13 July 2011
From
AVAC
Two studies show that drugs used to treat AIDS can be used to prevent HIV infection, too

Two new studies done in three African countries have shown for the first time that AIDS drugs taken daily can cut by more than half a person’s chance of becoming infected with HIV through heterosexual intercourse.

Published
13 July 2011
From
Washington Post
Global Survey of Men Who Have Sex with Men Shows Widespread Lack of Access to HIV Services, Little Knowledge of PrEP

Poor access linked to homophobia, youth particularly vulnerable A new global survey of more than 5,000 men who have sex with men (MSM) has shown that less than half of MSM around the world have easy access to lifesaving HIV

Published
12 July 2011
From
Moreover.com HIV/AIDS feed
SOUTH AFRICA: Promise and peril in ARV-based prevention

South African experts at this week's national AIDS conference cautioned that treatment-based prevention still presents a range of questions about how to translate research into practice, deciding which ARV-based prevention to use, who should get it, and whether the country can afford it.

Published
10 June 2011
From
IRIN Plus News
Ready to launch: “ADAPT” study looks at intermittent dosing of PrEP

Investigators at the HIV Prevention Trials Network (HPTN) Annual Meeting Monday received an update on a study looking to ease the pill burden on those wishing to benefit from pre-exposure prophylaxis (PrEP).

Published
07 June 2011
From
Science Speaks
Pre-exposure prophylaxis can significantly lower risk of getting HIV, but is the public buying?

Researchers used consumer marketing techniques to gauge acceptance of PrEP among high-risk groups in Lima, Peru. They found that study participants were generally supportive of PrEP but that out-of-pocket costs had the greatest impact — even more than the drug's effectiveness — on their willingness to use it.  

Published
03 June 2011
From
Health Canal
AHF: Gilead Must Halt FDA Approval of Truvada as HIV Prevention After PrEP Study in Women Fails

tTe AIDS Healthcare Foundation (AHF) renewed its call on Gilead Sciences to slow its fast track pursuit of its application for FDA approval of use of its AIDS drug as a possible form of HIV prevention.

Published
19 April 2011
From
AIDs Healthcare Foundation
FEM-PrEP Closure: Is PrEP ready for the world?

In July 2010 the world of HIV prevention felt the first tremor of hope that the fight against the virus that causes AIDS was at a turning point in its history after the pivotal CAPRISA trial (a “game changer”) showed that a topical gel containing an antiretroviral (ARV) used to treat

Published
19 April 2011
From
Incidence 0

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.